MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma (Q36413108)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma |
scientific article |
Statements
MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma (English)
Yong-Qing Tong
Bei Liu
Hong-Yun Zheng
Jian Gu
Hang Liu
Feng Li
Bi-Hua Tan
Melanie Hartman
1 September 2015
25024-25033
1 reference
1 reference